Clinical Trials
5 trialsNCT06833112 2025-02-18
Interleukin-17 (IL-17) Inhibitor in Combination With Tumor Necrosis Factor α (TNFα )Inhibitor for the Treatment of Ankylosing Spondylitis
The Affiliated Hospital Of Guizhou Medical University
Phase 4 Not yet recruiting
NCT02492217 2020-11-03
Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients
Universidade Nova de Lisboa
Phase 4 Completed
NCT02893254 2018-06-04
Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3 Completed
NCT02456363 2015-05-28
Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
Chung Shan Medical University
Phase 2 Unknown
NCT00085644 2011-04-21
ATLAS
Abbott
Phase 3 Completed